ANGPT1 and glaucoma: Emphasizing the potential of these signaling molecules as novel glaucoma therapies, we found that an ANGPT1-mimetic could specifically induce developmental SC remodeling and growth in wild-type and Angpt1ΔNC eyes and lower IOP in healthy adult eyes without pathological angiogenesis.